Methods for treating ER+, HER2-, HRG+ breast cancer using combination therapies comprising an anti-ErbB3 antibody

• 收藏
• 分享

专利权人:

Merrimack Pharmaceuticals; Inc.

发明人:

Czibere, Akos,Finn, Gregory J.,Zhang, Hong

申请号：

AU2017235450

公开号：

AU2017235450A1

申请日:

2017.03.15

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Provided herein are compositions and methods for treating ER+, HER2- HRG+ breast cancer (e.g., metastatic ER+, HER2- breast cancer) in a patient by administering to the patient an anti-ErbB3 antibody (

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/